Indian Pharma Companies Launch Generic Semaglutide Injections For Diabetes
New Delhi: Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost ...
New Delhi: Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost ...
Washington: US President Donald Trump’s announcement of sweeping prescription drug price cuts under a “Most Favoured Nation” policy has put ...